The Daily Record (Maryland)

Letter to the editor: BGE misrepresented PSC electrification study

I feel compelled to rebut several misrepresentations made by Mark Case, BGE’s vice president of regulatory policy, in a recent article, “Electrification will strain Maryland’s grid. The question is by ...
Financial Post

PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, a Global Prospective Cohort to Support the Development of New Treatments for Primary Sclerosing ...

We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, ...
Business Wire

Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies

- Mirum to host conference call to discuss analyses, today, June 17 at 8:30 a.m. ET/5:30 a.m. PT FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced ...
Seeking Alpha

Mirum: Maintaining Buy Rating On VOLIXIBAT PSC Treatment Data Q2 2026

The last time I spoke about Mirum Pharmaceuticals, Inc. (MIRM) it was in a Seeking Alpha article entitled "Mirum Pharmaceuticals: After Phase 2 Miss, An iBAT Inhibitor On Deck To Drive Value." With ...
Nature

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Table 1 Association summary statistics across four newly associated PSC risk loci Figure 1: Odds ratios (and their 95% confidence intervals) for PSC, UC and CD across the six PSC-associated SNPs ...